[e-drug] Olle Hansson Award 2007

[prasadini@haiap.org]

E-DRUG: Olle Hansson Award 2007
----------------------------------

[To respond DO NOT CLICK REPLY. Please respond to prasadini@haiap.org ]

To recognize the work of an individual from a developing country who 
best demonstrates the qualities of Olle Hansson in promoting the 
rational use of drugs.

'It is time to act! It is time to act for all of us who believe in human 
dignity and justice'.
                            *- Olle Hansson*

The Award is named in honour of Olle Hansson, a Swedish paediatric 
neurologist internationally known for his advocacy of SMON (Subacute 
myelo-optic neuropathy) victims who were paralyzed or blinded after 
using clioquinol, an antidiarrhoeal drug. Olle Hansson was a powerful 
campaigner against unethical promotion and marketing of drugs. In many 
ways, he represented the conscience of the medical profession.
His influence was felt not only in Sweden and Japan, which have 
thousands of SMON victims, but also in Europe and developing countries. 
Olle Hansson will be remembered by all who campaign for the rational use 
of drugs.

Although he died of cancer on May 23, 1985, at the age of 49, he remains 
a continuing source of inspiration for public interest workers 
everywhere. May 23 is commemorated each year as 'Olle Hansson Day'.

The Award was first given in 1987. The recipients included Dr Mira Shiva 
of India, Dr Alfredo Bengzon of the Philippines and Prof Dzulkifli Abdul 
Razak of USM, Malaysia and Dr K Balasubramaniam most recently.

Nominations are invited for the Olle Hansson Award. This Award for 2007 
recognizes the work of an individual from a developing country who has 
contributed the most to:

-  Promoting the concepts of essential drugs and their rational use, and

-  Increasing the awareness among consumers of the dangers of irrational 
and hazardous drugs.

Nominations for the award, which can come from any individual or 
organization, should contain:

1.  A one-page biodata of the candidate (including educational 
background, positions held, affiliations, honours and awards).

2.  A 500-word statement of the nominee's qualities and achievements in 
the field of rational drug use. Please provide  documentation of work done.

3.  A recent photograph of the nominee.

4.  The nominator's name, affiliation and address.

*Closing Date*
Nominations will close on *30th March 2007*.

*Announcement of Award winner*
The recipient will be chosen by an international panel of judges, and 
named on Olle Hansson Day, May 23 2007.

*The Prize*
The award, which is given annually, carries a prize of US$2,000 and a 
commemorative certificate.

*Management
*The Olle Hansson Award Fund is managed by Health Action International 
Asia - Pacific (HAIAP) which is the Asia - Pacific arm of the HAI global 
network.

HAIAP is a network of organizations and individuals involved in health 
and pharmaceutical issues.  HAIAP upholds health as a fundamental human 
right and aspires for a just and equitable world in which there will be 
among others regular access to essential medicines to all who need 
them. HAIAP actively promotes the concept of Essential Drugs their 
rational and economic use through advocacy, research education and 
action campaigns.

Please send nominations to:
Prasadini Perera
Project Officer
Health Action International Asia-Pacific (HAIAP)
No. 05 Level 02, Frankfurt Place
Colombo 04
Sri Lanka
Tel: + 9411 2554353
Fax: + 9411 2554570
E-mail: prasadini@haiap.org 

Website: www.haiap.org